{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T13:16:05Z","timestamp":1758287765190,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jdcr.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T11:24:53Z","timestamp":1750677893000},"page":"38-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination of mechanical debridement and interleukin 12 or interleukin 23 therapy for refractory facial pyoderma gangrenosum with NOD2 mutation"],"prefix":"10.1016","volume":"63","author":[{"given":"Morgan","family":"Vague","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Onoday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex G.","family":"Ortega Loayza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2025.06.019_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdcr.2025.06.019_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319851640","article-title":"TNF-\u03b1 inhibitors in the treatment of hidradenitis suppurativa","volume":"10","author":"Savage","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"issue":"14","key":"10.1016\/j.jdcr.2025.06.019_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-023-01931-3","article-title":"Pyoderma gangrenosum: treatment options","volume":"83","author":"Dissemond","year":"2023","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jdcr.2025.06.019_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ecco-jcc\/jjac124","article-title":"NOD2 in Crohn's disease-unfinished business","volume":"17","author":"Ashton","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jdcr.2025.06.019_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221102283","article-title":"Targeting IL12\/23 in ulcerative colitis: update on the role of ustekinumab","volume":"15","author":"Pugliese","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"10.1016\/j.jdcr.2025.06.019_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/intimm\/dxy021","article-title":"Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1","volume":"30","author":"Szymanski","year":"2018","journal-title":"Int Immunol"},{"issue":"5","key":"10.1016\/j.jdcr.2025.06.019_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40257-024-00875-y","article-title":"Human inborn errors of immunity in pyoderma gangrenosum: a systematic review","volume":"25","author":"Oprea","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2025.06.019_bib8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jdcr.2025.06.019_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.70135","article-title":"Local wound care management for pyoderma gangrenosum","volume":"21","author":"Haroon","year":"2024","journal-title":"Int Wound J"},{"key":"10.1016\/j.jdcr.2025.06.019_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2147\/CCID.S374534","article-title":"Recalcitrant ulcerative pyoderma gangrenosum of the leg responsive to tildrakizumab: a case report","volume":"15","author":"Leow","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625002802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625002802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T09:02:31Z","timestamp":1758186151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625002802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":10,"alternative-id":["S2352512625002802"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.06.019","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of mechanical debridement and interleukin 12 or interleukin 23 therapy for refractory facial pyoderma gangrenosum with NOD2 mutation","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}